Biffi A - Search Results

1

A randomized placebo-controlled study on high-dose oral algal docosahexaenoic acid supplementation in children with cystic fibrosis.

Alicandro G, Faelli N, Gagliardini R, Santini B, Magazzù G, Biffi A, Risé P, Galli C, Tirelli AS, Loi S, Valmarana L, Cirilli N, Palmas T, Vieni G, Bianchi ML, Agostoni C, Colombo C. Alicandro G, et al. Among authors: biffi a. Prostaglandins Leukot Essent Fatty Acids. 2013 Feb;88(2):163-9. doi: 10.1016/j.plefa.2012.10.002. Epub 2012 Dec 21. Prostaglandins Leukot Essent Fatty Acids. 2013. PMID: 23266209 Clinical Trial.

2

Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.

Colombo C, Faelli N, Tirelli AS, Fortunato F, Biffi A, Claut L, Cariani L, Daccò V, Prato R, Conese M. Colombo C, et al. Among authors: biffi a. Int J Immunopathol Pharmacol. 2011 Apr-Jun;24(2):423-32. doi: 10.1177/039463201102400215. Int J Immunopathol Pharmacol. 2011. PMID: 21658316 Free article.

3

Restoration of bacterial killing activity of human respiratory cystic fibrosis cells through cationic vector-mediated cystic fibrosis transmembrane conductance regulator gene transfer.

Biffi A, Sersale G, Cassetti A, Villa A, Bordignon C, Assael BM, Conese M. Biffi A, et al. Hum Gene Ther. 1999 Aug 10;10(12):1923-30. doi: 10.1089/10430349950017284. Hum Gene Ther. 1999. PMID: 10466626

4

Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs.

Bragonzi A, Dina G, Villa A, Calori G, Biffi A, Bordignon C, Assael BM, Conese M. Bragonzi A, et al. Among authors: biffi a. Gene Ther. 2000 Oct;7(20):1753-60. doi: 10.1038/sj.gt.3301282. Gene Ther. 2000. PMID: 11083497

5

Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungs.

Bragonzi A, Boletta A, Biffi A, Muggia A, Sersale G, Cheng SH, Bordignon C, Assael BM, Conese M. Bragonzi A, et al. Among authors: biffi a. Gene Ther. 1999 Dec;6(12):1995-2004. doi: 10.1038/sj.gt.3301039. Gene Ther. 1999. PMID: 10637451

6

Safety of arylsulfatase A overexpression for gene therapy of metachromatic leukodystrophy.

Capotondo A, Cesani M, Pepe S, Fasano S, Gregori S, Tononi L, Venneri MA, Brambilla R, Quattrini A, Ballabio A, Cosma MP, Naldini L, Biffi A. Capotondo A, et al. Among authors: biffi a. Hum Gene Ther. 2007 Sep;18(9):821-36. doi: 10.1089/hum.2007.048. Hum Gene Ther. 2007. PMID: 17845130

7

Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.

Cesani M, Plati T, Lorioli L, Benedicenti F, Redaelli D, Dionisio F, Biasco L, Montini E, Naldini L, Biffi A. Cesani M, et al. Among authors: biffi a. Gene Ther. 2015 Jun;22(6):496-502. doi: 10.1038/gt.2015.10. Epub 2015 Mar 12. Gene Ther. 2015. PMID: 25762283

8

[Gene therapy in pediatrics].

Aiuti A, Cappelli B, Biffi A, Marktel S, Roncarolo MG. Aiuti A, et al. Among authors: biffi a. Minerva Pediatr. 2009 Dec;61(6):775-8. Minerva Pediatr. 2009. PMID: 19935549 Italian. No abstract available.

9

Metachromatic leukodystrophy - mutation analysis provides further evidence of genotype-phenotype correlation.

Biffi A, Cesani M, Fumagalli F, Del Carro U, Baldoli C, Canale S, Gerevini S, Amadio S, Falautano M, Rovelli A, Comi G, Roncarolo MG, Sessa M. Biffi A, et al. Clin Genet. 2008 Oct;74(4):349-57. doi: 10.1111/j.1399-0004.2008.01058.x. Epub 2008 Sep 11. Clin Genet. 2008. PMID: 18786133

10

Metachromatic leukodystrophy: an overview of current and prospective treatments.

Biffi A, Lucchini G, Rovelli A, Sessa M. Biffi A, et al. Bone Marrow Transplant. 2008 Oct;42 Suppl 2:S2-6. doi: 10.1038/bmt.2008.275. Bone Marrow Transplant. 2008. PMID: 18978739 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

485 results

Search Page